EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results

Sarah A Hosgood iD, Tom Moore, Alex Walker, Michael L Nicholson

Artificial Organs · 2025

DOI: 10.1111/aor.14909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Sarah A Hosgood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, Perfusion, Kidney, Cytokines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stoneygate Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The interleukin 1 (IL‐1) cytokine group plays a key role in sterile inflammation and may be an important target for transplant‐related renal injury. This study examined the effects of anakinra, a non‐specific IL‐1 receptor antagonist, administered during normothermic machine perfusion (NMP) of porcine kidneys.

Method

Paired porcine kidneys ( n = 5 pairs) underwent 15 min of warm ischemia plus 2 h of static cold storage in ice. Kidneys were then perfused with autologous whole blood using an ex vivo NMP platform. Kidneys were randomly allocated to receive anakinra or vehicle administered at the start of NMP. Cortical biopsies were collected at baseline before ischemic injury and at the end of NMP. Functional parameters were recorded and calculated, and inflammatory markers were measured by qPCR and ELISA techniques.

Results

During NMP, there were no statistically significant differences in renal blood flow, urine output, creatinine clearance or fractional excretion of sodium in the anakinra and control groups. The administration of anakinra significantly downregulated transcriptional expression of IL‐6, Fas ligand and intercellular adhesion molecule 1 ( p = 0.029, 0.029, 0.028, respectively).

Conclusion

Anakinra, an IL‐1 receptor blocker, successfully attenuated the downstream inflammatory and immune‐mediated response within the kidney during NMP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin 1 Receptor Antagonist ProteinPerfusionKidneyCytokinesOrgan PreservationReceptors, Interleukin-1AnimalsSwineKidney TransplantationDown-RegulationWarm Ischemia

Stichwörter der Autor:innen

anakinranormothermic machine perfusionrenal transplantation

Substanzen

Interleukin 1 Receptor Antagonist ProteinCytokinesReceptors, Interleukin-1

Autor:innen und Institutionen

  • Department of Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

ORCID-Profile: Sarah A Hosgood

Förderung

  • Stoneygate Trust

Zitieren

APA

Hosgood, S. A., Moore, T., Walker, A., & Nicholson, M. L. (2025). IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results. Artificial Organs. https://doi.org/10.1111/aor.14909

Vancouver

Hosgood SA, Moore T, Walker A, Nicholson ML. IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results. Artificial Organs. 2025. doi:10.1111/aor.14909

BibTeX
@article{Hosgood2025,
  author = {Hosgood, Sarah A and Moore, Tom and Walker, Alex and Nicholson, Michael L},
  title = {IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.14909}
}
Kostenlos starten →